Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Novo Nordisk, the company behind Ozempic and Wegovy, says that they are years away from catching up to the demand of their drugs, and that they have stopped producing starter doses of Wegovy altogether, as they are struggling to keep up with the current number of patients on the drug
This impending patent cliff is a material headwind for Novo Nordisk, but price reductions will drive a substantial uplift in the volume of patients on injectable semaglutide, through preferential reimbursement (by state or PMI payors) and improved affordability for the self-pay segment
& Kane, M
How Amazon Pharmacys Same-Day GLP-1 Delivery is Bypassing the Corner Drugstore For the past three years, the historic boom in GLP-1 weight-loss medications has been plagued by two massive bottlenecks: infuriating supply chain shortages and an incredibly opaque pricing system at the pharmacy counter
Women of childbearing potential must be counseled on avoiding pregnancy while on MB, and if they become pregnant, the drug should be stopped and appropriate medical advice sought
PLOS ONE, 15(9), e0239252
